Upper gastrointestinal cancer
Conditions
Interventions
Chinese traditional medicine group:Traditional Chinese medicine
Chinese traditional medicine group:Support therapy
Chemotherapy group:Standard chemotherapy regimens
Chemotherapy group:Support therapy
Sponsors
China Academy of Chinese Medical Sciences Xiyuan Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Subjects eligible for enrollment must meet all of the following criteria: 1. Men or women aged 18 years or older; 2. Provide signed informed consent. The subject is capable of understanding and complying with parameters as outlined in the protocol and able to sign informed consent; 3. Diagnosis of adenocarcinoma of the stomach, T2 or T3 or T4, N0 or N1 or N2 or N3 (Diagnosis Criteria for Primary Gastric Cancer, WS 316-2010), - low 1/3 location(antrum and pylori); No evidence of other distant metastasis; 4. Patients have undergone radical resection of gastric cancer within 6-8 months.
Exclusion criteria
Exclusion criteria: Subjects meeting any of the following criteria must not be enrolled in the study: 1. Pregnant or lactating females; 2. Significant neurological or psychiatric disorders (psychotic disorders, dementia or seizures) that would prohibit the understanding and giving of informed consent; 3. History of serious cardiovascular/ cerebrovascular /hepatic /renal/hematopoietic diseases; 4. History of another malignancy; 5. Hypersensitivity to any drug of the study regimen; 6. Participated in other clinical trials within 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| endoscopic;Biopsy histologic examination;Chest CT; | — |
Countries
China
Contacts
Public ContactCai Yidong
China Academy of Chinese Medical Sciences Xiyuan Hospital
Outcome results
None listed